• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 2.63% 7.4¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI
US to reschedule weed
21/05/24 4 1.2K
21/05/24 Last post  $$$$$$$$ Comments Created with Sketch.  4  Views Created with Sketch.  1.2K 
NTI
International Recognition
17/05/24 2 773
17/05/24 Last post  levendful Comments Created with Sketch.  2  Views Created with Sketch.  773 
NTI 14/05/24 38 9.6K
TRENDING NEWS

Australian-listed companies chase the rainbow of the renewable energy market

NEWS
24 May 2024
14/05/24 Last post  Bluebush Comments Created with Sketch.  38  Views Created with Sketch.  9.6K 
NTI
Chart - NTI
2 3
11/05/24 139 53K
11/05/24 Last post  Ozibobby Comments Created with Sketch.  139  Views Created with Sketch.  53K 
NTI 09/05/24 49 13K
09/05/24 Last post  $$$$$$$$ Comments Created with Sketch.  49  Views Created with Sketch.  13K 
NTI 08/05/24 0 215
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  215 
NTI 08/05/24 0 243
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  243 
NTI 06/05/24 4 1.1K
06/05/24 Last post  Guzz Comments Created with Sketch.  4  Views Created with Sketch.  1.1K 

See All Discussions arrow Created with Sketch.

Timeline

Notice of Change of Auditor
08 May 18:28
 
Change of Director's Interest Notice
08 May 13:58
 
Investor Webinar on Rett Syndrome Clinical Trial Results
06 May 09:35
 
Investor Presentation
06 May 09:34
 
Rett Syndrome Phase I/II trial shows significant benefits
06 May 09:34
 
Trading Halt
03 May 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
7.4¢
Change
-0.002(2.63%)
Mkt cap ! $75.28M
Open High Low Value Volume
7.6¢ 7.7¢ 7.4¢ $309.2K 4.073M

Buyers (Bids)

No. Vol. Price($)
1 45202 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 30000 1
View Market Depth
Last trade - 15.31pm 24/05/2024 (20 minute delay) ?
Last
7.4¢
  Change
-0.002 ( 2.63 %)
Open High Low Volume
7.6¢ 7.7¢ 7.4¢ 135838
Last updated 15.09pm 24/05/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.